Mar 25, 2022
Cessation of the CF Bitcoin US Settlement Price and CF Ether-Dollar US Settlement Price
The Administrator hereby announces the cessation of the below benchmarks from the CF Cryptocurrency Index Family:
|
Benchmark |
CFB Ticker |
Bloomberg |
|
CF Bitcoin US Settlement Price |
XBTUSD_US_RR |
CFXBTUSN |
|
CF Ether Dollar US Settlement Price |
ETHUSD_US_RR |
CFETHUSN |
To promote an orderly transition and minimise any market impact these benchmarks will continue to be published and provision shall cease from 1200 London time on April 25th 2022, meaning that the last values to be published shall be for April 24th 2022.
In accordance with the Administrators policies no consultation will be conducted prior to this cessation due to neither benchmark being utilised as a Benchmark under Article 3.7 of the Benchmarks Regulations.
Alternative Benchmarks
Alternative benchmarks to the two that are the subject of this announcement are available from the Administrator and are listed below, they are determined using the same calculation methodology and published at the same time as the benchmarks that are the subject of this announcement and are available to license from the Administrator
|
Benchmark |
Alternative
Benchmark |
CFB Ticker |
Bloomberg Ticker |
|
CF Bitcoin US Settlement Price |
CME CF Bitcoin Reference Rate- New York Variant |
BRRNY |
BRRNY |
|
CF Ether Dollar US Settlement Price |
CME CF Ether-Dollar Reference Rate- New York Variant |
ETHUSD_NY |
ETHUSD_NY |
Should any market participants have any questions or queries please do not hesitate to contact [email protected]
Should any users wish to file a complaint regarding this cessation process this can be done confidentially at [email protected]
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
